These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8649865)

  • 21. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.
    Mousses S; Gokgoz N; Wunder JS; Ozcelik H; Bull S; Bell RS; Andrulis IL
    Br J Cancer; 2001 Jun; 84(12):1635-9. PubMed ID: 11401317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.
    Meyers FJ; Gumerlock PH; Chi SG; Borchers H; Deitch AD; deVere White RW
    Cancer; 1998 Dec; 83(12):2534-9. PubMed ID: 9874460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic losses and metastatic ability of mouse tumor cell clones derived from a heterozygous mouse.
    Mafune Y; Asakura H; Kominami R
    Oncogene; 1994 Aug; 9(8):2191-6. PubMed ID: 8036005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
    Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
    Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].
    Taubert H; Würl P; Meye A; Bache M; Kroll J; Lautenschläger C; Thamm B; Holzhausen HJ; Hinze R; Schmidt H; Berger D; Rath FW
    Verh Dtsch Ges Pathol; 1998; 82():340-4. PubMed ID: 10095457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.
    Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S
    Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
    Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
    Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.
    Anderson M; Sladon S; Michels R; Davidson L; Conwell K; Lechner J; Franklin W; Saccomanno G; Wiest J
    J Cell Biochem Suppl; 1996; 25():185-90. PubMed ID: 9027617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of subcellular localization of p53 protein in human glioblastomas.
    Ali IU; Schweitzer JB; Ikejiri B; Saxena A; Robertson JT; Oldfield EH
    Cancer Res; 1994 Jan; 54(1):1-5. PubMed ID: 8261427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma.
    Bot FJ; Sleddens HF; Dinjens WN
    Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
    Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
    Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distant metastases in ovarian cancer: association with p53 mutations.
    Sood AK; Sorosky JI; Dolan M; Anderson B; Buller RE
    Clin Cancer Res; 1999 Sep; 5(9):2485-90. PubMed ID: 10499623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients.
    Taubert H; Meye A; Würl P
    Cancer Res; 1996 Sep; 56(18):4134-6. PubMed ID: 8797580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
    Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
    J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.